APO-Pemetrexed pemetrexed 500 mg (as disodium) powder for injection vial

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Aktivna sestavina:

pemetrexed disodium hemipentahydrate, Quantity: 604 mg (Equivalent: pemetrexed, Qty 500 mg)

Dostopno od:

Arrotex Pharmaceuticals Pty Ltd

INN (mednarodno ime):

pemetrexed disodium hemipentahydrate

Farmacevtska oblika:

Injection, powder for

Sestava:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; mannitol

Pot uporabe:

Intravenous Infusion

Enote v paketu:

1

Tip zastaranja:

(S4) Prescription Only Medicine

Terapevtske indikacije:

Malignant Pleural Mesothelioma,Pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,Non-Small Cell Lung Cancer (NSCLC),Pemetrexed, in combination with cisplatin, is indicated for initial treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology.,Pemetrexed, as monotherapy, is indicated for the treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Povzetek izdelek:

Visual Identification: White to either light yellow or green-yellow powder.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status dovoljenje:

Registered

Datum dovoljenje:

2014-09-04